Search company, investor...

Predict your next investment

Venture Capital
tvm-capital.com

Investments

117

Portfolio Exits

35

About TVM Capital

TVM Capital is a group of globally acting venture capital and private equity firms with an operating track record of 30 years. TVM Capital funds operate globally with dedicated Life Science venture capital funds advised by group members TVM Life Science Management in Montreal and TVM Capital in Munich, and its healthcare private equity fund managed by TVM Capital Healthcare out of Dubai.

Headquarters Location

Ottostr. 4

Munich, D-80333,

Germany

+49 (89) 998 992-0

Want to inform investors similar to TVM Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest TVM Capital News

Kazakhstan investor backs TVM SE Asia healthcare fund

Jun 2, 2023

Send to Qazaqstan Investment Corporation (QIC), a private equity fund-of-funds set up by the Kazakhstan government, has invested in a Southeast Asia fund managed by TVM Capital Healthcare. The size of the LP commitment and the target corpus were not disclosed. TVM, a healthcare specialist based in Dubai and Singapore, is also in the market with a Middle East and North Africa (MENA) fund... To continue reading...

TVM Capital Investments

117 Investments

TVM Capital has made 117 investments. Their latest investment was in Rapid Micro Biosystems as part of their Series D on May 5, 2018.

CBI Logo

TVM Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/2/2018

Series D

Rapid Micro Biosystems

$60M

Yes

7

6/23/2014

Series C

Definiens

$20.4M

No

1

10/23/2013

Series A

F-star Alpha

$13M

Yes

1

10/1/2012

Series B

Subscribe to see more

$99M

Subscribe to see more

10

7/25/2012

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/2/2018

6/23/2014

10/23/2013

10/1/2012

7/25/2012

Round

Series D

Series C

Series A

Series B

Series D

Company

Rapid Micro Biosystems

Definiens

F-star Alpha

Subscribe to see more

Subscribe to see more

Amount

$60M

$20.4M

$13M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

1

1

10

10

TVM Capital Portfolio Exits

35 Portfolio Exits

TVM Capital has 35 portfolio exits. Their latest portfolio exit was Biognosys on January 04, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/4/2023

Corporate Majority

$99M

9

10/3/2022

Merger

$99M

1

5/31/2022

Acquired

$99M

1

10/27/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

7/16/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/4/2023

10/3/2022

5/31/2022

10/27/2021

7/16/2021

Exit

Corporate Majority

Merger

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

9

1

1

10

10

TVM Capital Team

13 Team Members

TVM Capital has 13 team members, including , .

Name

Work History

Title

Status

Robert Schneider

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Robert Schneider

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.